Prognostic significance of PCNA grade in malignant melanoma
Open Access
- 1 December 1993
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 20 (6) , 498-503
- https://doi.org/10.1111/j.1600-0560.1993.tb00677.x
Abstract
Proliferating cell nuclear antigen (PCNA) grade (a semi-quantitative assessment of the entire tumor profile) and estimation whether PCNA grade is low (0-50% positive cells) or high (51-100% positive cells) has been demonstrated to be of prognostic significance in gastric carcinoma. Sixteen vertical growth phase melanomas with 8 or more years of clinical follow-up were reacted with antibody to PCNA. PCNA grade was independently evaluated by both authors without knowledge of clinical outcome. PCNA grade was subsequently correlated with clinical outcome and other prognostic indicators. Agreement in assigning PCNA grade was noted between the two observers in 13/16 cases. However, PCNA grade failed to accurately predict patient survival or death. Additionally, PCNA grade was not significantly correlated with other recognized prognostic attributes. While interpretation of the prognostic significance of PCNA grade based upon this small series of cases should be conservative, a semi-quantitative estimate of PCNA-positive cells appears to have little utility in predicting the clinical outcome in malignant melanoma.Keywords
This publication has 14 references indexed in Scilit:
- Toxicological and Pathological Applications of Proliferating Cell Nuclear Antigen (PCNA), A Novel Endogenous Marker for Cell ProliferationCritical Reviews in Toxicology, 1993
- Mitotic indices, anti‐PCNA immunostaining, and AgNORs in thick cutaneous melanomas displaying paradoxical behaviourThe Journal of Pathology, 1992
- A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fractionThe Journal of Pathology, 1991
- Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.Journal of Clinical Pathology, 1991
- The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosisHistopathology, 1991
- Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA)Histopathology, 1991
- Determination of proliferating fractions in malignant melanomas by anti‐PCNA/cyclin monoclonal antibodyHistopathology, 1991
- Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasmsThe Journal of Pathology, 1990
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989
- Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis.The Journal of cell biology, 1988